BlueLinx Holdings Inc. 8-K

What Happened

• BlueLinx Holdings, Inc. (BXC) filed an 8-K on May 19, 2026 reporting results of its 2026 Annual Meeting of Stockholders held following a March 20, 2026 record date.
• Of 7,867,196 shares outstanding, 7,133,560 shares were represented (quorum present). Nine director nominees were voted on; eight nominees were re‑elected and one nominee, Mitchell B. Lewis, was not re‑elected.
• Stockholders also ratified Ernst & Young LLP as the company’s independent registered public accounting firm, approved the advisory (non‑binding) executive compensation vote (say‑on‑pay), and approved an amendment to the 2021 Long‑Term Incentive Plan to increase shares reserved for issuance.

Key Details

• Shares outstanding (record date): 7,867,196; shares represented at meeting: 7,133,560.
• Director votes (example): Mitchell B. Lewis — For: 2,604,527; Against: 3,325,567 (not re‑elected). Other nominees received majority For votes and were re‑elected (broker non‑votes: 1,198,409).
• Auditor ratification (EY): For 7,122,739; Against 10,258; Abstain 563.
• Advisory say‑on‑pay: For 5,874,819; Against 55,435; Abstain 4,897 (plus 1,198,409 broker non‑votes).
• 2021 Long‑Term Incentive Plan amendment: For 3,843,084; Against 2,090,468; Abstain 1,599 (plus 1,198,409 broker non‑votes).

Why It Matters

• Board composition changed: eight directors returned and one nominee (Mitchell B. Lewis) was not re‑elected, which affects the company’s governance and oversight going forward.
• Ratifying Ernst & Young confirms the external auditor for fiscal 2026 (year ending Jan 2, 2027), which is material for financial reporting continuity.
• The non‑binding approval of executive compensation indicates shareholder support for pay practices described in the proxy, while the approved amendment to the 2021 Plan increases the pool of shares available for equity awards (potential source of future dilution).